CoChat

Spectrum of Fibrotic Lung Diseases

· 2020 · New England Journal of Medicine
Cited by 126

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

To the Editor: The review article by Wijsenbeek and Cottin (Sept. 3 issue)1 provides an excellent overview of the spectrum of fibrotic lung diseases. To this discussion, we would add IgG4-related disease, a distinct primary disease causing interstitial lung disease. IgG4-related disease may affect all parts of the human body (including the lungs), may mimic such conditions as cancer and sarcoidosis, and is an increasingly recognized inflammatory disease characterized by progressive fibrosis. Reported manifestations of IgG4-related lung disease include tumorlike lesions, enlargement of hilar or mediastinal lymph nodes, bronchiectasis, bronchovascular nodules, organizing pneumonia, isolated non-specific interstitial pneumonia,2,3 and interstitial pneumonia with autoimmune features.2-4 The timely diagnosis and treatment of IgG4-related lung disease is important to prevent further progression of fibrosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmc2031135

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 126

Metadata

Venue
New England Journal of Medicine
Published
2020-12-17
Volume
383
Issue
25
Pages
2485-2486
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W3110819535
Cited by
126
References
2
FWCI
15.73
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.